Curemark Garners $18,500,000 New Funding

  • Feed Type
  • Date
    10/10/2013
  • Company Name
    Curemark
  • Mailing Address
    411 Theodore Fremd Ave Rye, NY 10580
  • Company Description
    Curemark is a socially driven biotechnology and development company whose focus is addressing the unmet health needs of individuals in the areas of neurology and gastrointestinal/pancreatic secretory deficiencies.
  • Website
    http://www.curemark.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $18,500,000
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    Curemark will use the funds for the completion and filing requirements for its New Drug Application (NDA) for CM-AT, the company’s autism treatment, and the development of the other therapies in its pipeline.
  • M&A Terms
  • Venture Investor
    Undisclosed

By posting a comment, you agree to our terms and conditions.